The deal will allow Novavax to lift its “going concern” warning, which it first issued in 2023 due to having “substantial doubt” about its ability to survive.
Novavax shares spike over 100% on Sanofi deal to commercialize Covid vaccine, develop combination shots
Related Posts
ADVERTISEMENT
Browse by Category
- Abu Dhabi 阿布扎比
- Animals
- Beijing 北京
- Blog
- Bolivia 玻利维亚
- Building
- China 中国
- Dubai 迪拜
- Finance News
- Flowers
- Food
- Free Talk
- Fujian 福建
- Guangdong 广东
- Hebei 河北
- Henan 河南
- Hiking
- Hong Kong 香港
- Investment
- Jiangxi 江西
- Kids
- Kuala Lumpur 吉隆坡
- Landscape
- Liaoning 辽宁
- Life in BJ
- Machine Learning
- Malaysia 马来西亚
- Mongolia 蒙古
- Movie
- Peru 秘鲁
- Photo News
- Photography
- Portrait
- Shanghai 上海
- Snapshot
- South America 南美
- South Korea 南韩
- Star
- Taiwan 台湾
- Tianjin 天津
- Tibet 西藏
- Travel
- United Arab Emirates 阿聯酋
Subscribe to Blog via Email
Join 30 other subscribers.
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company